PTK2 and neoplasm: Current research on the crosstalk between these immune checkpoints with FAK is lacking, but the various mechanisms by which FAK inhibition enhances response to immune checkpoint inhibition by altering T cell function and the tumor stroma likely applies to other immune checkpoint targets.